Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Avis
CAR
$4.97B
| $111M | 0.09% |
3,456,900
-83,500
| -2% | -$2.5M |
|
252
Bio-Techne
TECH
$11.2B
| $111M | 0.09% |
2,024,604
-243,876
| -11% | -$12.8M |
|
253
Black Hills Corp
BKH
$5.59B
| $111M | 0.09% |
1,414,215
+24,300
| +2% | +$1.87M |
|
254
DuPont de Nemours
DD
$19.5B
| $111M | 0.09% |
1,372,468
+1,153,899
| +528% | +$95.8M |
|
|
MLNX
255
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $110M | 0.08% |
941,487
+69,504
| +8% | +$7.9M |
|
|
KL
256
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $110M | 0.08% |
2,496,866
+357,973
| +17% | +$15.9M |
|
257
Wingstop
WING
$3.03B
| $109M | 0.08% |
1,258,705
-131,995
| -9% | -$11M |
|
258
Johnson Controls International
JCI
$93.7B
| $108M | 0.08% |
+2,662,144
| New | +$112M |
|
259
Regeneron Pharmaceuticals
REGN
$82.1B
| $108M | 0.08% |
288,400
-110,418
| -28% | -$37.1M |
|
260
Darden Restaurants
DRI
$24.9B
| $108M | 0.08% |
992,792
+85,900
| +9% | +$9.75M |
|
261
Viavi Solutions
VIAV
$9.47B
| $108M | 0.08% |
7,211,888
+1,614,600
| +29% | +$24.2M |
|
262
Ligand Pharmaceuticals
LGND
$5.76B
| $107M | 0.08% |
1,636,966
-317,755
| -16% | -$21.2M |
|
263
W.W. Grainger
GWW
$61.3B
| $106M | 0.08% |
313,400
+123,200
| +65% | +$39.1M |
|
264
Arista Networks
ANET
$250B
| $106M | 0.08% |
8,324,800
+3,152,000
| +61% | +$41.5M |
|
|
COR
265
DELISTED
Coresite Realty Corporation
COR
| $105M | 0.08% |
940,300
-106,000
| -10% | -$12.2M |
|
266
Builders FirstSource
BLDR
$8.08B
| $105M | 0.08% |
4,126,819
+1,394,719
| +51% | +$33.3M |
|
267
Cognizant
CTSH
$26.4B
| $105M | 0.08% |
1,687,074
+1,671,274
| +10,578% | +$103M |
|
268
Mercury Insurance
MCY
$5.86B
| $105M | 0.08% |
2,147,160
+112,160
| +6% | +$5.64M |
|
269
BCE
BCE
$21.8B
| $105M | 0.08% |
2,256,028
-445,872
| -17% | -$21.4M |
|
270
Brookdale Senior Living
BKD
$3B
| $104M | 0.08% |
14,372,920
+1,382,595
| +11% | +$10.3M |
|
271
Melco Resorts & Entertainment
MLCO
$2.16B
| $104M | 0.08% |
4,312,176
+1,502,876
| +53% | +$32.7M |
|
272
Valero Energy
VLO
$93.3B
| $104M | 0.08% |
1,110,188
+1,105,100
| +21,720% | +$104M |
|
273
Morningstar
MORN
$7.33B
| $103M | 0.08% |
683,516
+17,646
| +3% | +$2.71M |
|
274
FirstCash
FCFS
$9.04B
| $103M | 0.08% |
1,279,786
-146,028
| -10% | -$12.3M |
|
275
Medifast
MED
$130M
| $102M | 0.08% |
933,215
+10,600
| +1% | +$1.03M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.